Beijing Tiantan Biological Products Co., Ltd. (BEIJING TIANTAN BIOLOGICAL PROD) Aktie
600161.SS
GeschlossenBEIJING TIANTAN BIOLOGICAL PROD
Market Cap
$25,468,542,976
Über Beijing Tiantan Biological Products Co., Ltd. (BEIJING TIANTAN BIOLOGICAL PROD) Aktie
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Unternehmensinformationen
100024 Beijing, China
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.